XML 29 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue:      
Total revenue $ 102,206 $ 70,119 $ 57,017
Cost of revenue:      
Total cost of revenue 92,161 69,784 61,076
Gross profit (loss) 10,045 335 (4,059)
Operating expenses:      
Research and development 32,431 31,849 25,008
Selling and marketing 30,488 16,044 15,181
General and administrative 52,437 56,091 61,729
Impairment charges 1,816 0 0
Total operating expenses 117,172 103,984 101,918
Loss from operations (107,127) (103,649) (105,977)
Interest income 1,686 13 791
Interest expense (5,057) (4,241) (3,307)
Other income (expense), net 3,168 (2,171) 585
Loss before provision for income taxes (107,330) (110,048) (107,908)
Provision for income taxes 0 0 0
Net loss attributable to common stockholders, basic and diluted $ (107,330) $ (110,048) $ (107,908)
Net loss per share, basic (USD per share) $ (0.59) $ (0.67) $ (0.73)
Net loss per share, diluted (USD per share) $ (0.59) $ (0.67) $ (0.73)
Weighted-average common shares used in computing net loss per share, diluted (in shares) 180,697,230 164,521,064 147,895,561
Weighted-average common shares used in computing net loss per share, basic (in shares) 180,697,230 164,521,064 147,895,561
Product      
Revenue:      
Total revenue $ 79,325 $ 51,865 $ 42,742
Cost of revenue:      
Total cost of revenue 71,238 51,780 49,347
Service      
Revenue:      
Total revenue 22,368 17,779 13,800
Cost of revenue:      
Total cost of revenue 20,923 18,004 11,729
Distribution rights      
Revenue:      
Total revenue $ 513 $ 475 $ 475